يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"Rudresh Pathak"', وقت الاستعلام: 0.99s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial

    المؤلفون: Thomas RE Barnes, Verity C Leeson, Carol Paton, Céire Costelloe, Judit Simon, Noemi Kiss, David Osborn, Helen Killaspy, Tom KJ Craig, Shôn Lewis, Patrick Keown, Shajahan Ismail, Mike Crawford, David Baldwin, Glyn Lewis, John Geddes, Manoj Kumar, Rudresh Pathak, Simon Taylor

    المصدر: Health Technology Assessment, Vol 20, Iss 29 (2016)

    مصطلحات موضوعية: citalopram, antipsychotic, schizophrenia, negative symptoms, randomised controlled trial, ssri antidepressant, antipsychotic augmentation, Medical technology, R855-855.5

    وصف الملف: electronic resource

    Relation: https://doaj.org/toc/1366-5278; https://doaj.org/toc/2046-4924

    URL الوصول: https://doaj.org/article/91794c91bb314b3c9a7f27e29e67c67d

    Full Text Finder
    أضف إلى المفضلة
  2. 2
    M11. Long-Term Antidepressant Treatment for Negative Symptoms in Schizophrenia: The ACTIONS Study

    المؤلفون: Shajahan Ismail, Shôn Lewis, Patrick Keown, Manoj Kumar, Glyn Lewis, Rudresh Pathak, John R. Geddes, Helen Killaspy, Thomas R. E. Barnes, David S. Baldwin, Mike J. Crawford, Simon Taylor, David Osborn, Verity C. Leeson, Thomas J. Craig, Carol Paton

    مصطلحات موضوعية: medicine.medical_specialty, business.industry, Citalopram, medicine.disease, Psychiatry and Mental health, Abstracts, Pharmacotherapy, Schizophrenia, Medicine, Antidepressant, Apathy, medicine.symptom, business, Adverse effect, Psychiatry, Adverse drug reaction, Avolition, Clinical psychology, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5453ffb30f8e81e0db1e2887aa783617
    https://europepmc.org/articles/PMC5475920/

    أضف إلى المفضلة
  3. 3
    Antidepressant controlled trial for negative symptoms in schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial

    المؤلفون: Patrick Keown, Céire Costelloe, Shajahan Ismail, Shôn Lewis, David Osborn, Glyn Lewis, John R. Geddes, Verity C. Leeson, Noemi Kiss, Rudresh Pathak, Thomas R. E. Barnes, Manoj Kumar, David S. Baldwin, Mike J. Crawford, Tom K. J. Craig, Judit Simon, Carol Paton, Simon Taylor, Helen Killaspy

    المساهمون: Department of Health

    المصدر: Health Technology Assessment, Vol 20, Iss 29 (2016)

    مصطلحات موضوعية: Male, Cost-Benefit Analysis, law.invention, 0807 Library And Information Studies, 0302 clinical medicine, Randomized controlled trial, law, media_common, Positive and Negative Syndrome Scale, Health Policy, Drug Synergism, Middle Aged, Antidepressive Agents, Treatment Outcome, 1117 Public Health And Health Services, Tolerability, lcsh:R855-855.5, Schizophrenia, Health Policy & Services, Antidepressive Agents, Second-Generation, Drug Therapy, Combination, Female, Schizophrenic Psychology, medicine.symptom, Research Article, Antipsychotic Agents, Adult, medicine.medical_specialty, Consensus, lcsh:Medical technology, Citalopram, Placebo, 03 medical and health sciences, Double-Blind Method, medicine, Humans, media_common.cataloged_instance, European union, Psychiatry, Avolition, Psychiatric Status Rating Scales, business.industry, medicine.disease, 030227 psychiatry, Clinical trial, 0806 Information Systems, Quality of Life, Physical therapy, business, 030217 neurology & neurosurgery

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f12042c08257b734df386c5123e1b36a
    http://ora.ox.ac.uk/objects/uuid:

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء